Acne vulgaris and postinflammatory hyperpigmentation
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Will be included female individuals, aged between 18 years and 48 years, with a phototype of I to IV and with complaint of hyperchromia after acne on the face verified by Baumman questionnaire
Exclusion criteria
Exclusion criteria: Pregnant and lactating women will be excluded who have is subjected to dermatological and / or cosmetic treatment in the face in the last 6 months, or who have active infection in the face (acne> grade I), disease dermatological or metabolic causing hyperpigmentation of the face, such as Syndrome Cushing's and Lupus Systemic Eritrematoso or hyperpigmentation from birth as nevus. Similarly, those who miss session 01 any of the groups are excluded
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected a reduction of at least 30% in the degree of oiliness of the skin of women undergoing treatment with mandelic and mandelic acid in the control group. Reduction of at least 10% of the area hyperpigmentation, with uniformity of skin tone in women treated with mandelic acid and retinoic compared to the control group.;Reduction of at least 30% of the area of hyperpigmentation, with uniformity of skin tone in the women treated with mandelic acid and retinoic acid in comparison to the control group, evaluated by means of the comparison of the photographic records before the beginning and one week after the end of the intervention . | — |
Secondary
| Measure | Time frame |
|---|---|
| Promoting improvement of at least 30% the aesthetic aspect of the skin in all the women involved in the present study evaluated through the global self-satisfaction scale before and one week after the end of the intervention. | — |
Countries
Brazil
Contacts
Universidade Federal de Mato Grosso do Sul